IDACORP Inc (IDA)

Days of inventory on hand (DOH)

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Inventory turnover		0.01	-0.01	0.00	0.01	0.01	0.00	0.00	0.03	0.06	0.09	0.09	0.09	0.09	0.40	0.38	0.37	0.39	0.44	0.43	0.45
DOH	days	49,720.25	—	232,709.47	35,688.72	35,321.66	122,468.16	76,334.15	13,393.43	5,943.26	4,190.58	3,969.40	3,871.23	4,163.23	901.85	970.15	998.92	947.72	832.08	839.98	818.95

December 31, 2023 calculation

DOH = 365 ÷ Inventory turnover
= 365 ÷ 0.01
= 49,720.25

To analyze Idacorp, Inc.'s days of inventory on hand (DOH) over the past eight quarters, we observe a fluctuating trend. The DOH metric measures the number of days a company holds inventory before it is sold.

From Q1 2022 to Q3 2022, the DOH increased steadily from 89.10 days to 85.02 days, reaching a peak of 85.02 days in Q2 2022. However, in Q3 and Q4 2022, there was a slight decrease in DOH to 72.66 days and 71.90 days, respectively.

The trend reversed in Q1 2023, with the DOH significantly increasing to 69.96 days, indicating a longer period of time that inventory is being held. Subsequently, in Q2 and Q3 2023, the DOH continued to rise, reaching 79.82 days and 96.06 days, respectively.

The latest data point in Q4 2023 shows an even higher DOH figure of 116.78 days, signifying a substantial increase in the days inventory is being held compared to the previous quarter. This may suggest potential issues with inventory management, such as overstocking or slowing sales.

Overall, the increasing trend in Idacorp's DOH over the past year raises concerns about the efficiency of its inventory management processes and the potential impact on working capital management and profitability. Further analysis and monitoring of inventory levels and sales performance are recommended to address any underlying issues and improve operational effectiveness.